Journal of Clinical Psychopharmacology (@JCPjournal) header
Journal of Clinical Psychopharmacology (@JCPjournal) profile picture

JCP keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents. Our podcast: https://teapawt.net/t.co/iXWmMM85rV

Lippincott Williams & Wilkins
Joined January 2011
Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)Photo by Journal of Clinical Psychopharmacology (@JCPjournal)
Reproductive safety data for #vortioxetine have been limited. A prospective @MGH registry analysis found no major malformations in 58 infants following 1st trimester exposure, providing reassuring preliminary evidence while larger studies are underway. 🔗 ovid.com/jnls/psychopharmaco…
1
2
66
Journal of Clinical Psychopharmacology retweeted
Somatic symptom disorder has no FDA-approved medication, and cognitive behavioral therapy isn’t widely accessible. In a new case report in the @JCPjournal , I describe a medication that may be worth a closer look.
1
2
3
43
❓Have a psychopharmacology-related question? Consider submitting it to the "Ask the Experts" section in @JCPjournal which provides a forum for presenting questions to psychopharmacology experts. Please email your questions to our Editorial Office at [email protected].
45
Can a common #antibiotic trigger acute #psychosis? A new JCP systematic review examines reported cases in children and adolescents and explores what may be an uncommon but important neuropsychiatric adverse effect. 🔗Read more in JCP: ovid.com/jnls/psychopharmaco…
1
53
For patients with treatment-resistant #schizophrenia who refuse oral clozapine, #intramuscular #clozapine may provide a bridge to treatment. A systematic review found successful transitions to oral therapy were commonly achieved within days. 🔗 Read more: ovid.com/jnls/psychopharmaco…
1
2
155
Insomnia is often multifactorial. This new Harvard South Shore #algorithm highlights diagnosis-driven treatment strategies for #insomnia accompanying common psychiatric disorders. 🔗 Read more in JCP: ovid.com/jnls/psychopharmaco…
68
Are we overlooking antidepressant #metabolites during therapeutic drug monitoring? A new JCP study found higher #desipramine levels in #imipramine nonresponders, despite similar imipramine levels. 🔗 Read more in JCP: ovid.com/jnls/psychopharmaco…
66
Is #kratom an #opioid? Kratom is often marketed as a safe, natural, non-addictive product. But a new JCP editorial and podcast argue that the scientific evidence tells a different story. A timely debate in #addictionmedicine. 🎧 ovid.com/jnls/psychopharmaco… 📰 jcpjournal.libsyn.com/kratom…
1
1
208
ADHD #stimulant #misuse is declining, but important public health concerns remain. Listen to our new podcast discussing a rapid review on misuse patterns, risks, and clinical implications. 🎧 Podcast: jcpjournal.libsyn.com/adult-… 📰 Article: ovid.com/jnls/psychopharmaco…
95
Could #inflammation help predict response to #esketamine? In a small study of treatment-resistant #depression, patients with higher baseline neutrophil-to-lymphocyte ratios were more likely to show sustained improvement with intranasal esketamine. 🔗 ovid.com/jnls/psychopharmaco…
98
Dr. Kolodny's guest editorial is available ahead-of-print on our website: 🔗 ovid.com/jnls/psychopharmaco…
Kratom is often described as a botanical substance with opioid-like effects, but @andrewkolodny argues that framing downplays what clinicians are increasingly seeing in practice. @JCPjournal medpagetoday.com/psychiatry/…
80
❓Have a psychopharmacology-related question? Consider submitting it to the "Ask the Experts" section in @JCPjournal which provides a forum for presenting questions to psychopharmacology experts. Please email your questions to our Editorial Office at [email protected].
1
1
85
What do we know about #cariprazine during #breastfeeding? Analysis of milk samples from 5 lactating women found low infant exposure, though reports of infant lethargy and concerns about metabolite accumulation warrant further study. 🔗Read more in JCP: ovid.com/jnls/psychopharmaco…
1
297
Do #pharmacogenomic tests improve patient-centered outcomes in #depression? This study found similar improvements in well-being and symptoms over 12 months regardless of whether clinicians had access to combinatorial pharmacogenomic testing results. 🔗 ovid.com/jnls/psychopharmaco…
60
Psychopharmacology is more than matching diagnoses to guidelines. RCTs and guidelines inform treatment, but they do not replace clinical judgment. Our podcast discussion of a new editorial focuses on this topic. 🎧 jcpjournal.libsyn.com/interm… 🧾 ovid.com/jnls/psychopharmaco…
1
171
GLP-1s and lithium: what could go wrong? In a new report from @MayoClinic, the authors discuss a case of severe #lithium toxicity requiring hemodialysis after #tirzepatide initiation in a patient with bipolar I disorder. 🎧 jcpjournal.libsyn.com/tirzep… 📰 ovid.com/jnls/psychopharmaco…
3
2
282
New pharmacovigilance data suggest that #olanzapine and #clozapine may be more strongly associated with pulmonary embolism than other antipsychotics. Whether this reflects medication effects, underlying severe mental illness, or both remains unclear. 🔗 ovid.com/jnls/psychopharmaco…
107
The Journal of Clinical Psychopharmacology is building a presence on @Bluesky, and we’d love for our @X community to be part of it. Follow us on Bluesky Social for early updates, featured research, and insight into psychopharmacology trends. 📲 psychopharm.bsky.social
1
211